Moderna shares rise 6% after the FDA reversed its decision not to review the flu vaccine
Following an earlier surge in pre-market trading, Moderna shares increased 6.4% to approximately $46.75 shortly after the market started on...
FDA
Drug manufacturers concerned about the legal risk of the FDA’s rapid review program
Six industry sources told Reuters that while more than six big pharmaceutical companies are taking part in the Trump administration's...
Juul is set to obtain U.S. regulatory approval for its e-cigarettes
The company announced to Forbes on Thursday that Juul will be granted approval from the Food and Drug Administration (FDA)...
FDA approves blood test to diagnose Alzheimer’s disease: first of its kind
The first blood test used to diagnose Alzheimer's disease was cleared by the Food and Drug Administration for marketing on...
Neuralink’s ‘Blindsight’ receives innovative device designation from FDA
Neuralink, Elon Musk's brain chip startup, declared that its experimental implant intended to restore vision has received “breakthrough device” designation...
FDA clears Neuralink to implant brain chip in second patient
According to a Wall Street Journal (WSJ) story published on Monday, the U.S. Food and Drug Administration (FDA) approved Neuralink,...
Neuralink: According to Musk’s company, the first patient with a brain chip plays online chess
https://twitter.com/neuralink/status/1770563939413496146 In a nine-minute live broadcast on X (previously Twitter), Noland Arbaugh plays online chess using a cursor. Following a...
Elon Musk claims that the first human Neuralink trial participant can use a brain implant to operate a computer mouse
In January, Neuralink successfully implanted their gadget in a human being. The gadget is precisely implanted in the brain by...
Elon Musk reports that his business Neuralink has successfully implanted its first chip into a human brain
Early findings revealed encouraging neural spikes or nerve impulses, and the patient is making a full recovery, he reported. According...
Founders Fund, backed by Thiel, raises $280 million for Musk’s Neuralink
Months after receiving permission for its first in-human clinical study, Peter Thiel's Founders Fund led a $280 million investment round...
